CVC Capital Partners Explores $2 Billion Sale of Dr Teal’s Parent Company
Key Facts
Amid a shifting landscape for consumer goods acquisitions, private equity firm CVC Capital Partners is reportedly exploring a sale of Parfums de Coeur (PDC), the parent company of the wellness brand Dr Teal’s. According to reports, the buyout firm is in the early stages of considering a divestiture to exit its investment in the personal care sector. Sources familiar with the matter indicate that the potential deal could value the company at approximately $2 billion.
The move highlights CVC's strategy to capitalize on the significant growth of the Dr Teal’s brand since its acquisition. Per market dynamics in the private equity space, firms are increasingly looking for exit opportunities in high-performing consumer segments. Parfums de Coeur remains a central asset in CVC’s portfolio, and a successful sale at the reported valuation would mark a significant mid-market event for the consumer goods industry.
Looking ahead, authoritative price data for related instruments was unavailable as of the close on September 8, 2026, leaving the valuation tied to ongoing private negotiations. With no specific upcoming catalysts for this sector in the immediate economic calendar, market participants will be watching for official confirmations regarding potential bidders or finalized deal terms, as the process currently remains in the exploration phase.